Conditions: Chronic Obstructive Pulmonary Disease
Keywords: COPD Bronchodilator
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 33
Healthy volunteers: no

Brief summary:
This study was intended to assess how well inhaled NVA237 opens up the airways of patients with mild, moderate or severe COPD over a 24 hour period after a 14 day treatment period.

Detailed description:

Arms:
arm 1: Placebo 50 μg capsules followed by NVA237 50 μg capsules for inhalation once daily with Concept 1 device. arm 2: NVA237 50 μg capsules followed by matching placebo 50 μg capsules for inhalation once daily with Concept 1 device.

Interventions: intervention 1: Placebo intervention 2: NVA237
Intervention descriptions: intervention 1: Matching placebo capsules were supplied for inhalation once daily with Concept 1 device. intervention 2: NVA237 50 μg capsules were supplied for inhalation once daily with Concept 1 device.

Protocol document: